Targeting DNA Topoisomerase II in Antifungal Chemotherapy
Topoisomerase inhibitors have been in use clinically for the treatment of several diseases for decades. Although those enzymes are significant molecular targets in antibacterial and anticancer chemotherapy very little is known about the possibilities to target fungal topoisomerase II (topo II). Rais...
Main Authors: | Kavya Kondaka, Iwona Gabriel |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/27/22/7768 |
Similar Items
-
Antifungal Activity of Capridine β as a Consequence of Its Biotransformation into Metabolite Affecting Yeast Topoisomerase II Activity
by: Iwona Gabriel, et al.
Published: (2021-02-01) -
DNA topoisomerases as molecular targets for anticancer drugs
by: Kamila Buzun, et al.
Published: (2020-01-01) -
‘Acridines’ as New Horizons in Antifungal Treatment
by: Iwona Gabriel
Published: (2020-03-01) -
Inhibitory effects of lapachol on rat C6 glioma in vitro and in vivo by targeting DNA topoisomerase I and topoisomerase II
by: Huanli Xu, et al.
Published: (2016-11-01) -
Topoisomerase II as a Novel Antiviral Target against Panarenaviral Diseases
by: Tosin Oladipo Afowowe, et al.
Published: (2022-12-01)